Home
Who We Are
What We Do
Corporate Responsibility
News
Careers
Investors
Patients and HCPS
Contact us
Careers | Investors | Patients and HCPS | Contact us
Careers Investors Patients and HCPS Contact us
Worldwide Offices
山东
甘李药业山东有限公司

甘李药业股份有限公司的全资子公司,于2019年9月在山东临沂成立。
主营业务:主要负责药品及医疗器械的生产等工作。

上海
甘李生物科技(上海)有限公司

甘李药业股份有限公司的全资子公司,于2020年在上海成立。
主营业务:国际商业合作(BD)

香港
甘李控股有限公司(香港)

甘李药业股份有限公司的全资子公司,于2020年在中国香港成立。
主营业务:国际商业合作(BD)

美国
甘李药业美国公司

甘李药业股份有限公司的全资子公司,于2014年在美国新泽西州成立。
主营业务:主要负责海外临床、注册及业务拓展等工作。

美国
甘李新泽西控股公司

甘李药业股份有限公司的全资子公司,于2020年在美国新泽西州成立。
主营业务:欧美业务、生产及销售。

美国
甘李新泽西生产公司

甘李药业股份有限公司的全资子公司,于2020年在美国新泽西州成立。
主营业务:欧美业务、生产及销售。

北京
甘李药业股份有限公司(总部)

1998年成立,位于北京通州经济开发区,拥有约20万平方米的产业园。

北京
北京甘甘科技有限公司

甘李药业股份有限公司的全资子公司,于2007年在北京成立。
主营业务:糖尿病治疗配套医疗器械的产品研发设计、新技术开发。

江苏
甘李药业江苏有限公司

甘李药业股份有限公司的全资子公司,于2015年在江苏泰州成立。 主营业务:化学药品生产基地。建设有多肽合成原料药车间、固体口服制剂车间(片剂)和化学原料药合成车间以及与之配套的办公、质检、仓储、环保等辅助设施。

江苏
甘甘医疗科技江苏有限公司

北京甘甘科技有限公司的全资子公司,于2017年在江苏泰州成立。 主营业务:着重于将相关研发成果转换为合规的生产经营活动。主要产品有笔式胰岛素注射器(秀霖笔®)、血糖仪、血糖试纸、笔式注射器(预装式)、一次性胰岛素笔用针头(秀霖针®)等。

德国
甘李药业欧洲有限责任公司

甘李药业股份有限公司的全资子公司,于2021年在德国成立。
主营业务:欧洲业务、临床及销售等。

Gan & Lee Pharmaceuticals Co., Ltd.

Founded in 1998, the company is located in Beijing, with an industrial base of approximately about 200,000 square meters.

Gan & Lee Pharmaceuticals Shandong Co., Ltd.

A wholly-owned subsidiary of the Company, established in Linyi, Shandong Province in China, 2019.
Main Business: the production of medicinal products and medical devices.

Beijing Gangan Technology Co., Ltd.

A wholly-owned subsidiary of the Company, which was established in Beijing, 2007.
Main Business: R&D of medical devices for diabetes treatment

Gangan Medical Technology Jiangsu Co., Ltd.

A wholly-owned subsidiary of Gangan Technology, established in Taizhou, Jiangsu Province in China, 2017.
Main Business: Converting relevant R&D results into compliant production and operation activities. The main products include pen-type insulin syringes (GanleePen), blood glucose meters, blood glucose test strips, pre-filled pens, disposable insulin pen needles (GanleeFine®), etc.

Gan & Lee Pharmaceuticals Jiangsu Co., Ltd.

A wholly-owned subsidiary of the Company, established in Taizhou, Jiangsu Province in China, 2015
Main Business: Chemical production base, which has a polypeptide synthesis raw material medicine production line, a solid oral preparation production line (tablet) and a chemical raw material medicine synthesis production line, as well as supporting facilities such as office, quality inspection, storage, and environmental protection.

Gan & Lee Holdings Limited

A wholly-owned subsidiary of the Company, established in Hong Kong in China, 2020.
Main Business: International Business Development

Gan & Lee Pharmaceuticals USA Corporation,

A wholly-owned subsidiary established by the Company, established in New Jersey, United States in 2014.
Main Business: overseas clinical, registration, business development.

G&L Holdings New Jersey Inc.

A wholly-owned subsidiary established by the Company, established in New Jersey, United States in 2020.
Main Business: International Business Development

G&L Manufacturing New Jersey Inc.

A wholly-owned subsidiary established by the Company, established in New Jersey, United States in 2020.
Main Business: US & European business, production, and sales.

Gan&Lee Pharmaceuticals Europe GmbH

A wholly-owned subsidiary established by the Company established in Germany in 2021.
Main Business: European business, clinical affairs, and sales.

Gan & Lee Pharmaceuticals Co., Ltd.

Founded in 1998, the company is located in Beijing, with an industrial base of approximately about 200,000 square meters.

Gan & Lee Pharmaceuticals Shandong Co., Ltd.

A wholly-owned subsidiary of the Company, established in Linyi, Shandong Province in China, 2019.
Main Business: the production of medicinal products and medical devices.

Beijing Gangan Technology Co., Ltd.

A wholly-owned subsidiary of the Company, which was established in Beijing, 2007.
Main Business: R&D of medical devices for diabetes treatment

Gangan Medical Technology Jiangsu Co., Ltd.

A wholly-owned subsidiary of Gangan Technology, established in Taizhou, Jiangsu Province in China, 2017.
Main Business: Converting relevant R&D results into compliant production and operation activities. The main products include pen-type insulin syringes (GanleePen), blood glucose meters, blood glucose test strips, pre-filled pens, disposable insulin pen needles (GanleeFine®), etc.

Gan & Lee Pharmaceuticals Jiangsu Co., Ltd.

A wholly-owned subsidiary of the Company, established in Taizhou, Jiangsu Province in China, 2015
Main Business: Chemical production base, which has a polypeptide synthesis raw material medicine production line, a solid oral preparation production line (tablet) and a chemical raw material medicine synthesis production line, as well as supporting facilities such as office, quality inspection, storage, and environmental protection.

Gan & Lee Holdings Limited

A wholly-owned subsidiary of the Company, established in Hong Kong in China, 2020.
Main Business: International Business Development

Gan & Lee Pharmaceuticals USA Corporation,

A wholly-owned subsidiary established by the Company, established in New Jersey, United States in 2014.
Main Business: overseas clinical, registration, business development.

G&L Holdings New Jersey Inc.

A wholly-owned subsidiary established by the Company, established in New Jersey, United States in 2020.
Main Business: International Business Development

G&L Manufacturing New Jersey Inc.

A wholly-owned subsidiary established by the Company, established in New Jersey, United States in 2020.
Main Business: US & European business, production, and sales.

Gan&Lee Pharmaceuticals Europe GmbH

A wholly-owned subsidiary established by the Company established in Germany in 2021.
Main Business: European business, clinical affairs, and sales.

Copyright © 2021 Gan & Lee Pharmaceuticals Co Ltd . All Rights Reserved.
Our websites

Subscribe

I read, agree with and accept all of the Privacy Policy and Terms of Use of this website.